SCHEMBL6204475

SCHEMBL6204475

[O]C(F)c1ccc(F)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.44
TDO2 P48775 2/20 0.44
HDAC3 O15379 1/20 0.43
HDAC4 P56524 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC7 Q8WUI4 1/20 0.43
HDAC2 Q92769 1/20 0.43
HDAC10 Q969S8 1/20 0.43
HDAC11 Q96DB2 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
HDAC9 Q9UKV0 1/20 0.43
HDAC5 Q9UQL6 1/20 0.43
ALDH1A1 P00352 2/20 0.38
CES2 O00748 1/20 0.38
CES1 P23141 1/20 0.38
LMNA P02545 1/20 0.38
ALPG P10696 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CA1 P00915 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7129754 0.81 IDO1 (0.48) IDO1TDO2HDAC3HDAC4HDAC1
SCHEMBL4048358 0.75 IDO1 (0.48) IDO1TDO2HDAC3HDAC4HDAC1
SCHEMBL1046731 0.74 IDO1 (0.42) IDO1TDO2HDAC3HDAC4HDAC1
SCHEMBL420435 0.73
SCHEMBL2732165 0.73 IDO1 (0.46) IDO1TDO2HDAC3HDAC4HDAC1
SCHEMBL4427290 0.73 IDO1 (0.46) IDO1TDO2HDAC3HDAC4HDAC1
SCHEMBL9240130 0.72 ALDH1A1 (0.47) IDO1TDO2HDAC3HDAC4HDAC1
SCHEMBL2489611 0.71 IDO1 (0.50) IDO1TDO2HDAC3HDAC4HDAC1
SCHEMBL21994503 0.71 IDO1 (0.44) IDO1TDO2HDAC3HDAC4HDAC1
SCHEMBL21840890 0.71 IDO1 (0.44) IDO1TDO2HDAC3HDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1506175-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDGF RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-02-16 EP disclosed
WO-2003097609-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDFG RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2003-11-27 WO disclosed